Model
Edge
Moonlake Immunotherapeutics
0001920509
Filing Type
4
Filing Date
12/9/2025
Updated
12/10/25, 2:29 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership